Lexicon Pharmaceuticals (LXRX) - Cost to borrow shares

Latest borrow fee for Lexicon Pharmaceuticals (LXRX) shares on Interactive Brokers: 0.9837% (annualized)

Shares available to borrow: 150000
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Lexicon Pharmaceuticals (LXRX) - cost to borrow in the last 7 days chart

Lexicon Pharmaceuticals (LXRX) - number of shares available to borrow in the last 7 days

Lexicon Pharmaceuticals (LXRX) - cost to borrow from 2024 to 2023

Lexicon Pharmaceuticals (LXRX) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company	Cost to borrow (% year)	Shares available	Country
Eterna Therapeutics ERNA	9.7066%	0.05 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	0.3225%	2.1 M	🇺🇸 USA
Ultragenyx RARE	0.25%	3.4 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	0.25%	4.2 M	🇺🇸 USA
Thermo Fisher Scientific TMO	0.3833%	10 M	🇺🇸 USA
Esperion Therapeutics ESPR	1.1402%	0.65 M	🇺🇸 USA
Illumina ILMN	0.3438%	4.3 M	🇺🇸 USA
Ligand Pharmaceuticals LGND	0.4512%	0.35 M	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions